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Queer quit: a pilot study of a smoking cessation
programme tailored to gay men
Maria Dickson-Spillmann1*, Robin Sullivan1, Benedikt Zahno2 and Michael P Schaub1
Abstract
Background: The prevalence of cigarette smoking among adult gay males is higher than that of heterosexuals.
There is a need for interventions adapted to gay culture. We conducted a pilot study using a modified version of a
British smoking intervention programme tailored to gay men in Switzerland. As the main outcome, we assessed
point prevalence smoking abstinence six months following programme attendance.
Methods: Seventy gay smokers attended seven weekly sessions in groups (median size = 5) taught by gay facilitators. A
quit day was set in session 3. Integral components of the intervention were: discussing nicotine replacement therapy,
performing carbon monoxide tests and forming ‘quit teams’. Seven-day point prevalence smoking abstinence,
mental and physical health and the frequency of alcohol and drug use were assessed at baseline, in session 7 and
at a six-month follow-up.
Results: Point prevalence abstinence significantly increased throughout the study (p = .00). At six months, 20
participants (28.6%) reported smoking abstinence over the previous 7 days. We observed increases in participants’
mental health between baseline and the six-month follow-up (p = .00). Participants who dropped out during the
programme or were lost to follow-up smoked more cigarettes and were more nicotine dependent than the
participants who were retained throughout the study duration (p ≤ .05).
Conclusions: This smoking cessation programme for gay men produced rates of point prevalence abstinence that
were similar to interventions for non-gay groups. The programme presented an opportunity for gay men to quit
smoking and interact with other gay non-smokers. Our results confirm the need to test this programme more
systematically with a view toward implementing it on a larger scale in Switzerland.
Trial registration: Current Controlled Trials ISRCTN36851118 (02 October 2013).
Keywords: Smoking cessation, Homosexuality, Pilot project
Background
Studies from Switzerland and other countries have shown
that the smoking prevalence among gay men is higher
than that of heterosexual men, even after controlling for
demographic variables [1]. Prevalence estimates range be-
tween 14–44% for heterosexual men and 25–49% for
homosexual men [2-6]. Although homosexuals have been
identified as a vulnerable population regarding the health
risks of smoking and the need for culture-sensitive inter-
ventions has been acknowledged [7], such interventions
have rarely been studied.
One study evaluated a seven-week group smoking ces-
sation programme adapted for gay men, provided by the
UK’s Gay Men’s Health Charity (GMFA) and based on a
smoking cessation programme approved by the National
Health Service [8]. The pillars of this programme were
group work, nicotine replacement therapy (NRT) and
peer support. ‘Quit cells’ of three to four participants
were created to promote partnered support. Assertiveness
exercises were used to enhance participants’ resistance to
temptations. The results showed that 76% (n = 44) of the
men who had set themselves a quit date in the third week
as part of the programme remained non-smokers until the
end of the programme. Long-term smoking abstinence,
however, was not assessed.
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Swiss gay smokers expressed widespread intentions to
quit smoking and a high interest in a culturally specific
smoking cessation programme [9]. The smokers in this
study reported that within the gay community, smoking
and going out to gay venues ‘belonged’ together. The
participants feared that quitting smoking, without being
provided appropriate support, would mean having to ab-
stain from the gay scene and possibly losing community
membership. Thus, the participants considered it im-
portant that any successful programme help to build a
non-smoking social network that would support them
beyond the end of the programme. Additionally, it was
found that gay healthcare organisations played an im-
portant role in communicating the risks of smoking to
gay men and that such communication may draw men
to cessation services.
In this article, we report the outcomes of a pilot study
evaluating a smoking cessation programme for gay men.
This programme is based on a similar program tested in
the UK [8]. Our primary aim was to assess the success
of the programme in terms of long-term point preva-
lence abstinence. Furthermore, we expected that by in-
creasing participants’ skills in coping with situations of
smoking temptation, participants’ ability to resist other
drugs and alcohol would also be enhanced, and thus con-
sumption of these substances would be reduced. We also
intended to evaluate the beneficial effects of programme
participation on depression and anxiety scores, two risk
factors for decreased mental health that are widespread
among homosexual men [10]. Thus, as secondary out-
comes, we wanted to evaluate the programme regarding
changes in mental health, physical health and other sub-
stance use. Qualitative feedback on programme obtained
from our facilitators and participants completed our
evaluation. From our findings, we hoped to gain infor-
mation on the potential success of this programme to
facilitate smoking cessation and improve other health
outcomes as well as to assess its attractiveness to the
target population. Given these positive evaluations, the
programme might be more rigorously tested and pos-
sibly implemented on a larger scale in Switzerland.
Methods
Study design
As this is a pilot study, we did not include a control
group. All participants underwent the same procedure.
We aimed at a minimum of five groups with 15 partici-
pants each (75 participants in total).
Programme design
In preparation for this pilot study, a personal meeting
between the group work manager at the GMFA and the
research manager at the Swiss Research Institute for
Public Health and Addiction (ISGF) was held to share
research intentions and practical experiences with the
programme. Following this meeting, two programme
manuals were kindly provided by the GMFA: one for fa-
cilitators and one for participants. The manuals were
translated into German by a bilingual employee of the
ISGF. While we maintained the programme structure,
we undertook minor modifications to the educational
content. These revisions included updating the informa-
tion on prescription medication used to treat smoking
addiction in session 1 (e.g., adding varenicline) or adapt-
ing smoking prevalence statistics to Switzerland. Table 1
summarises the content of each session.
The programme consisted of seven weekly closed-
group sessions, each lasting 2.5 hours. In line with the
GMFA’s programme, sessions 1 and 2 of the programme
had an educational focus. These sessions were mainly
managed by the facilitator. To support participants in
seeking medication, a letter addressed to their general
practitioners was made available announcing the partici-
pants’ attendance in the programme and requesting a pre-
scription of NRT or other prescription medicine. Smoking
cessation at session 3 (‘quit day’) was mandatory for all
participants. From ‘quit day’ in session 3 onwards, priority
was given to the programme’s social component. Peer sup-
port was reinforced by shifting from vertical (facilitator) to
horizontal peer support (quit teams). Group discussions
Table 1 Main topics of each session (slightly modified
from the GMFA manual)
Session Main topics
Session 1 Facts about smoking and smoking cessation
What can you expect when you quit smoking?
Minimise the side effects – NRTs and prescription
medication
Contraindications for prescription medication
What about prescription medication and HIV
anti-retroviral therapy?
The issues of combination usage of NRT and
prescription medication
Session 2 Are you ready to stop smoking?
Carbon monoxide and what it does to you
Carbon monoxide monitor
Stop Smoking action plan
Smoking diary
Preparing for Quit Day
Session 3 Quit Day
Quit Team Contact Sheet
Session 4 Inexpensive holistic stop-smoking ideas
Session 5 Weight gain issues
Session 6 Your support network
Session 7 Celebration
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were initiated, and the quit teams were encouraged to en-
gage in leisure time activities together until and beyond
the end of the course.
Carbon monoxide (CO) measurements were taken in
each session using a breath carbon monoxide monitor
(PiCO Smokerlyzer; Bedfont Scientific Ltd., Harrietsham,
Maidstone, Kent, UK) to confirm smoking cessation, moni-
tor smoking abstinence and visualise physical health im-
provements. In addition, participants indicated the number
of cigarettes smoked in the previous 7 days and (if any) the
type and the number of units used of nicotine replacement
therapy during the previous week. These assessments were
included as part of the programme to make participants
aware of their progress.
Setting
The programme was delivered by four facilitators who
were recruited from a gay health centre in Zurich (Check-
point). The facilitators were between 25 and 45 years of
age, male, gay, and had previous teaching experience in a
psychosocial context. All facilitators were non-smokers.
To promote consistency across the groups, facilitators
were instructed to follow the programme manual for facil-
itators. Furthermore, in preparation for their task, each
future facilitator co-taught the programme together with
the head facilitator who had long-standing experience in
teaching smoking cessation classes. The programme took
place in conference rooms across the city of Zurich on
weekday evenings. The programme ran nine times be-
tween January 2009 and June 2010.
Six-month follow-up
Six calendar months following session 7, each partici-
pant was provided with an electronic follow-up form
that could be filled in and returned online or printed out
and sent back via postal mail. Non-responders received
a reminder every two weeks following the initial mailing
together with an invitation to perform the follow-up via
telephone. Follow-ups, which took place between Sep-
tember 2009 and November 2010, were managed by a
student employee of the ISGF.
Ethical aspects and informed consent
This pilot study was performed in line with the 2004
Declaration of Helsinki. The study design was publicly
available on the website of the Swiss Tobacco Control
Fund. (www.bag.admin.ch/tabak_praevention). Following
clarification with the Cantonal Ethical Committee of
Zurich, the present study did require formal ethical ap-
proval as we did not administer drugs or perform the
study in a hospital, nursing home or institution of justice
(www.kek.zh.ch). Informed consent was obtained from
the participants prior to their participation in the study.
Participants were asked to present the signed form to
the facilitators at the first session.
Participants
Gay male smokers older than 18 years with strong inten-
tions to quit were recruited for the study. Based on ad-
vice from the GMFA’s group work manager, we created
diversified groups of participants from various back-
grounds to produce more representative results and to
reduce the likelihood of participants cheating or having
mental blockades caused by social pressure. Advertise-
ments were placed in local gay media and on websites;
leaflets containing information about the course were
left at gay bars in the city of Zurich. Moreover, an ani-
mated website was designed (http://queer-quit.ch) that
included additional information about the course, the
subject of smoking and the enrolment procedure. Poten-
tial participants were invited to attend an information
session at Checkpoint in which information concerning
the smoking prevalence in gay men, results from the
programme in the UK and details about the current
programme were presented. At the end of the informa-
tion session, potential participants had the opportunity
to sign up for the study.
Measures and instruments
To assess the main outcome, participants were asked in
session 7 and at the six-month follow-up whether they
had smoked during the previous seven days. Sociodemo-
graphic information (date of birth, nationality, education),
age at first cigarette, number and type of previous quit at-
tempts and the Fagerstrom Test for Nicotine Dependence
(FTND) [11] were collected in session 1. Data on mental
and physical health and 30-day point prevalence of drug
and alcohol use were collected in sessions 1 and 7 and at
the six month follow-up using the German short version
of the Beck Depression Inventory (BDI-V) [12,13], the
Beck Anxiety Inventory (BAI) [14,15], the Short-Form
Health Survey 12 (SF-12) [16,17] and a shortened version
of the European Addiction Severity Index [18].
To evaluate the programme and determine possible
barriers and enablers for smoking cessation, qualitative
interviews were conducted with the facilitators, and the
participants were asked to complete a short voluntary
feedback form at the end of the programme.
Data preparation and analysis
In the course of data preparation, we recoded FTND re-
sponse categories to indicate that a higher value meant
higher nicotine dependence, and we created a sum score
for every respondent. In accordance with clinical research,
where BDI and BAI scores are frequently reported in
terms of sum scores, for our sample description we also
calculated sum scores for these measures. For the analysis
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of BDI and BAI as secondary outcomes of the programme,
however, we used the mean BDI and BAI values of those
participants with no more than two (10%) missings. Using
the two SF-12 subscales, a mental and a physical compo-
nent score were created according to instructions [19]. Al-
cohol and drug usage was coded into different categories
based on frequency of use that ranged from “never” to “3
or more times a day”.
This study is based on an intention-to-treat design. For
the evaluation of our main outcome of point prevalence
smoking abstinence, those participants who did not pro-
vide follow-up data were counted as relapsed smokers. To
investigate whether point prevalence abstinence increased
over time, we applied generalised estimating equation
(GEE) analyses to account for correlations between re-
peated observations. The dichotomous variable “7-day
smoking abstinence” was entered into the model as the
dependent variable, with “time” (i.e. baseline, session 7 or
six-month follow-up) as the predictor. GEE analyses were
also applied to secondary outcomes.
We analysed baseline differences between dropouts at
the six-month follow-up and those who stayed in the
programme using t-tests and X2-tests. All analyses were
conducted in STATA 12 SE (College Station, Texas, USA).
Open-ended, qualitative feedback regarding the pro-
gramme was coded into different categories by one
rater; this categorisation was then reviewed by another
rater. In cases of disagreement, the raters discussed
both alternatives until they reached a consensus.
Results
Participant flow
Seventy participants were recruited for the study. At the
first session, the median group size was five (Min = 2,
Max = 21). Session 3 was attended by 59 participants,
which represented 84.3% of all participants who had
attended the first session. Forty-seven men attended
the last session (67.1%). Thirty-eight participants were
reached at the six-month follow-up (54.3%). Complete
datasets including baseline, session 7 and the six-month
follow-up were available for 35 participants (50.0%).
Participant characteristics
Table 2 summarises the baseline demographics, health
characteristics and smoking habits of the participants.
As defined by the FTND which ranges from 0 to 10, the
study sample consisted of medium-dependent smokers
(M = 4.1, SD = 2.3), who had undertaken more than three
quit attempts before beginning the programme. Our
sample was older than a Swiss sample of 477 gay men in
a health survey (35 years) [6] and did not contain as
many university-educated individuals (38.6% vs. 12.9%),
but rather contained more participants with vocational
training (28.4% vs. 51.5%). Depression scores according
to the BDI-V were higher in our sample (M = 28.75,
SD = 15.19) than in a representative sample of the German
male population (M = 18.8, SD = 13.5) [12].
Self-reported point prevalence abstinence, CO
measurements and use of NRT
Of the participants who attended session 7, one reported
having smoked a cigarette during the previous week. All
Table 2 Sample description (N = 70)
Variable n (%)
Age (M, SD) 42.96 (9.66)
Nationality
Switzerland 51 (72.9)
Germany 9 (12.9)
Other 10 (14.3)
Education
Compulsory education 0 (0.0)
Vocational education (apprenticeship) 36 (51.5)
General education (Matura certificate) 4 (5.7)
University of applied science 20 (28.6)
University 9 (12.9)
Other 1 (1.3)
Smoking cessation
Quit attempts (M, SD) 3.38 (2.49)
NRT* experienced 36 (51.4)
Prescription medication** experienced 13 (18.6)
Smoking habits
Fagerstrom Nicotine Tolerance score (M, SD) 4.13 (2.33)
Age at smoking initiation (M, SD) 18.58 (4.14)
Years of smoking (M, SD) 22.83 (9.30)
Drug use
Alcohol: 3–4 times per week 19 (27.1)
Cannabis: at least once in last 30 days 32 (45.7)
Cocaine: at least once in last 30 days 8 (11.4)
Party drugs: at least once in last 30 days 17 (24.3)
Health
HIV positive 9 (12.9)
Mental component scale (M, SD) 55.78 (8.11)
Physical component scale (M, SD) 52.48 (6.06)
Depression
BDI-V (M, SD) 28.75 (15.19)
Lifetime diagnosis 13 (18.6)
Anxiety
BAI (M, SD) 9.31 (6.83)
Lifetime diagnosis 6 (8.6)
*Nicotine replacement therapy.
**Prescription medication used to treat smoking addiction (e.g., bupropion).
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other participants reported having been smoke-free (65.7%
abstinent participants on an intention-to-treat basis). The
mean CO score at session 7 was 2.72 (SD = 1.56). At the
six-month follow-up, 20 participants reported that they
had not smoked in the previous seven days (28.6% of the
original 70 participants). According to the GEE analyses,
“time” had a significant impact on abstinence rates (OR
2.01, CI 1.60 - 2.52, p = .00).
In session 3, 28 of 59 (47.5%) participants reported
using NRT. Varenicline tablets were the predominant
therapy (used by 11 participants), followed by 2 mg gum
(5), 4 mg gum (3) and 16 h patches (3). In session 7, 18
of 47 (38.3%) participants used NRT, with tablets still be-
ing the most frequently used therapy (9 participants),
followed by the 2 mg gum (4).
Changes in substance use and mental and physical health
The GEE analyses revealed changes over time in depres-
sion (b = −.16, SE = .04, p = .00, CI [−.24] – [−.08]), anxiety
(b = −.07, SE = .02, p = .00, CI [−.12] – [−.03]) and the
mental component score of the SF-12 (b = 2.09, SE = .67,
p = .00, CI 0.78 – 3.41). Depression and anxiety scores
decreased by 0.29 and 0.16 points, respectively, while the
mental component score increased by 1.39 points. In
contrast, “time” did not affect frequency of alcohol and
drug use in the previous 30 days, nor did it affect phys-
ical wellbeing (all p > .05). No differences in depression
and anxiety scores were found between participants
who were abstinent at six months and those who had
relapsed (p > .05).
Differences between retained participants and those lost
to follow-up
Participants who were available for the six-month follow-
up and those who were not differed with regard to the
number of daily cigarettes smoked at baseline during
the previous month. Retained participants smoked 2.11
(SD = 0.76) cigarettes, while those lost to follow-up
smoked 2.56 (SD = 0.89) (p = .02). Similarly, the latter
participants were slightly more nicotine dependent at
baseline (M = 5.24, SD = 2.50) than those who were avail-
able at follow-up (M = 4.11, SD = 2.07, p = .05). Similar dif-
ferences in these two smoking-related variables were
observed between the participants who attended session 7
and those who did not (results not shown). No differences
were found between the retained participants and drop-
outs with regards to other smoking-related variables,
sociodemographic and health characteristics or substance
use at either session 7 or follow-up.
Participants’ feedback and interviews with facilitators
At the end of the programme, 36 participants (77 of
those present at session 7) completed the short feedback
form. Table 3 shows the results of the closed-end
questions in the participant satisfaction survey. When
asked through open-ended questions for positive experi-
ences in the programme, 13 participants mentioned the
general points of ‘group dynamics’ and ‘group experi-
ence’. More specific points included ‘group communica-
tion’, which was mentioned by 13 participants, ‘control’
(2 participants) and ‘having a common aim’ (2 partici-
pants). Four participants reported that they perceived
the regularity of meetings as positive. In relation to spe-
cific programme elements, two participants found the
CO test and two participants found the information ma-
terials to be particularly helpful. Only one person expli-
citly mentioned the fact that the programme was only
for gay participants as being particularly positive. When
asked for negative aspects of the programme, seven par-
ticipants noted that they had problems with the skills
trainings, and two mentioned that they had hoped for
more group discussions.
The interviews with the facilitators suggested that they
would have preferred the use of NRT and prescription
medication to be explained by a general practitioner
with more knowledge about side effects and contraindi-
cations. The facilitators considered group sizes of 10 to
12 participants to be optimal, particularly for group
discussions.
Discussion
We evaluated a smoking cessation programme tailored
to gay men, a group with a high smoking prevalence. At
the end of the programme, two-thirds of participants re-
ported smoking abstinence. Self-reported abstinence by
the participants was validated by the presence of low CO
levels (< 3 ppm) observed at the last session [20,21]. At
the six-month follow-up, more than one-quarter of par-
ticipants reported smoking abstinence during the previ-
ous week. At the same time, we observed improvements
in the mental health of all participants during the study
period, both in those who quit smoking and those who
relapsed. Participation in the programme did not lead to
lower consumption of illegal drugs and alcohol. The
programme was well accepted by both the facilitators
and the participants. Use of NRT decreased by nearly
10% from session 1 to session 7. Qualitative responses
showed that the participants particularly appreciated the
group dynamics and the group experience of the course.
This finding underlines the importance for our partici-
pants to experience smoking cessation together with
other gay men, which is a desire expressed in the con-
text of a previous study [9].
In the UK study [8], 58% of all participants who had
attended the first session were abstinent at the last ses-
sion. Our abstinence rate at session 7 of 66% is therefore
comparable to that of the UK study. Our result of ab-
stinence in 28.6% of participants at six-month follow-up
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is similar to that of other group intervention studies of
smoking cessation in non-gay samples: Huber and Gast-
ner [22] reported 23 and 29% abstinence in participants,
without and with NRT, respectively; Schmitz et al. [23]
observed 22%, and 30% abstinence without and with
bupropion, respectively; and Romand, Gourgou and
Sancho-Garnier [24] reported 20% abstinence without
medication. Considering that our sample was more bur-
dened with depression than the general male population
and that negative affect could be a barrier to smoking
cessation [25,26], the similarity of our abstinence rate
with the rates observed in other studies is remarkable.
The observed improvement in mental health could be at-
tributed to the fact that, through attending the programme,
all participants had the opportunity to actively address
their nicotine addiction and to acquire the knowledge ne-
cessary to control this addiction. This process was perhaps
more important for participants’ mental health than their
actual success in quitting. Contrary to our expectation, the
programme did not affect consumption of other drugs.
This might be because the programme (e.g. the assertive-
ness exercises) was specific to smoking tobacco, because
the participants may not have considered their use of other
drugs as being problematic, or may have perceived the
consumption of other drugs as a separate issue.
Our study has some limitations that merit discussion.
Due to the absence of a control condition in our pilot
study and our rather small sample, we are not able
to draw conclusions regarding the efficacy of the
programme for the general population. Participants
who dropped out (i.e. no attendance at session 7 or lost
to follow-up) at baseline smoked more cigarettes per
day and were more nicotine-dependent than those who
completed the study. It may be that heavier smokers
generally encounter more difficulties when attempting
smoking cessation [27]. However, this outcome could
also indicate that the programme – through its struc-
ture or its content – addressed the needs of lighter
rather than heavier smokers. Because of the absence of
a control condition, we cannot assess the influence of
pre-existing intentions to quit smoking on our partici-
pants, which were possibly stronger than those of their
peers who did not attend the programme and, as such,
could have enhanced participants’ success regardless of
program participation.
We are unable to distinguish between the effects of
the general programme structure, those that occurred
through the specific adaptations made for the gay popula-
tion and those that occurred through the implementation
(e.g. gay facilitators, gay-only participants) on smoking be-
haviour. We do not know whether our study participants
would have benefited from the programme to the same
extent if heterosexual participants had also participated, if
heterosexual facilitators had taught the program or if the
content was not specific to the gay culture. A previous
study found that cessation rates were nearly identical be-
tween homosexual (59%) and heterosexual (57%) male
participants [28] at the last session of a non-tailored smok-
ing cessation programme; rates comparable to those we
observed. Follow-up results were not reported for that
study. Thus, the effect of tailoring the program specifically
to the homosexual population remains unknown. Qualita-
tive remarks, however, indicated that many participants
appreciated the atmosphere of open discussion at the ses-
sions. It is likely that such an atmosphere more easily
evolved through the match between facilitators’ and par-
ticipants’ sexual orientation.
Further research is necessary to identify the specific
programme components that contributed in a statistically
significant way to the effectiveness of this pilot interven-
tion. Prior research has shown that general problem-
solving elements (skills training, relapse prevention and
stress management) are likely to be beneficial, as is intra-
treatment social support [29]. The next step will be to es-
tablish the efficacy of the programme in the context of a
randomized-controlled trial. If efficacy can be proven, the
programme will be implemented nationwide.
Future research could focus on evaluating the pro-
gramme in homosexuals with HIV. Due to the double
physical burden, smokers with HIV are at enhanced risk
for pulmonary, cardiovascular and bone diseases, as well
as malignancies and generally lowered immune responses
[30]. In addition, smoking is associated with lower adher-
ence to highly active antiretroviral therapy [31]. Thus, pro-
moting smoking cessation in HIV-infected smokers is a
particular concern.
Conclusions
More than a quarter of our participants remained
smoking-abstinent for at least six months. The participants
Table 3 Program evaluation by the participants (N = 36)
Item Very much agree Partly agree Don’t agree
n % n % n %
I am happy with the program content. 26 72.2 10 27.8 0 0.0
The program was easy to understand. 34 94.4 2 5.6 0 0.0
I can use the program content in my everyday life. 31 86.1 2 13.9 0 0.0
The program structure helped me achieve smoking cessation. 29 80.6 6 16.7 1 2.8
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and the facilitators provided positive evaluations of the
programme that particularly emphasised the group experi-
ence. Thus, for homosexual men who can afford the time
to commit to seven weekly sessions, this programme is a
promising way to quit smoking and to develop relationships
with other non-smoking homosexuals. A randomized-
controlled trial of the programme and its implementation
at a larger scale in Switzerland will yield more generalizable
results on its success. A particular focus of research related
to the programme will be smoking cessation in homosex-
uals with HIV.
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